SEC Tracker
Get the app

Possible new INO shares

INODilution

Known so far: no new shares from the prospectus covers read · shelf room about $24.8M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $24.8M, maybe lower
  • One third of float $24.8M ($74.3M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $24.8M on the S-3 of Jul 2, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $74.3M public float stated as of Jun 30, 2025, $24.8M, nothing sold off it in the last 12 months; 2 more sales off the shelf with no size read, so the room may be lower. Sources: S-3 Jul 2, 2026, effective Jul 10, 2026 · public float, as of Jun 30, 2025 · 424B5 Jul 29, 2026 · 424B5 Jul 30, 2026.

What could become new Inovio Pharmaceuticals (INO) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (103.4M shares, +95% from 53.1M on Aug 8, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

103M

Nov 2024 to Aug 2026: from 26.1M to 103M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.